Navigation Links
Significant funding for type 1 diabetes research
Date:1/25/2008

Researchers from the Peninsula Medical School in the South West of England have received funding of $480,000 from the Juvenile Diabetes Research Foundation, the worlds largest charitable funder of type 1 diabetes research, to study a unique collection of pathology samples from people who died soon after diagnosis of Type 1 diabetes.

The aim of the research, which will use around 70 samples collected by Dr Alan Foulis, a pathologist from Glasgow, is to identify the triggers that cause Type 1 diabetes and the sequence of events that lead to the first symptoms.

Type 1 diabetes develops when the body is unable to produce its own insulin. Type 1 diabetes is an autoimmune disease which strikes in childhood, adolescence, or adulthood, but lasts a lifetime. It accounts for between five per cent and 15 per cent of all people with diabetes. It also requires multiple injections of insulin daily or a continuous infusion of insulin through a pump. Insulin, however, is not a cure for diabetes, nor does it prevent its eventual and devastating complications which may include kidney failure, blindness, heart disease, stroke, and amputation.

The research will cover new ground by seeking to identify what it is that initiates the process in man, and will consider the possibility that Type 1 diabetes could be triggered by environmental factors such as certain viruses. It will also map the progression of the disease in relation to the immune system and will seek to establish if there is a defined sequence of events, and why this is so.

Professor Noel Morgan from the Peninsula Medical School commented: This is very exciting research which can be expected to provide new insights into the causes of diabetes. If we can identify the triggers that set Type 1 diabetes into motion, and the sequence of events that lead to symptoms, there is potential for the development of therapies to prevent or halt the disease.

He added: The process can start as long as five years before the first symptoms appear. If we can understand what it is that goes on in this period, it could provide a window of opportunity for us to develop therapies and treatments to stop it.

The funding from the Juvenile Diabetes Research Foundation will be used to support a post-doctorate researcher and a graduate student researcher for three years. The research will be based at the Peninsula Medical School but the team also includes collaborators from Glasgow and the School of Pharmacy & Biomolecular Sciences, University of Brighton.

Said Professor Morgan: We are very grateful to the Juvenile Diabetes Research Foundation for this grant. The outcomes of our research could well have a fundamental effect on the prevention and treatment of Type 1 diabetes in the future.

Diabetes affects 2.3 million people in the UK, and 20.8 million in the USA. In the UK, a further 750,000 people may have the disease without knowing it in the USA this figure is 6.2 million.


'/>"/>

Contact: Andrew Gould
media@pr-works.co.uk
01-392-686-107
The Peninsula College of Medicine and Dentistry
Source:Eurekalert

Related medicine news :

1. Study finds significant differences in protocols hospitals use to determine brain death
2. Breast cancer risk varies significantly among BRCA1 and BRCA2 carriers
3. Despite efforts, significant racial disparities in cancer therapy still exist
4. Tonsillectomy significantly improves quality of life in adult and pediatric patients
5. Significant changes in plastic surgery expected in 2008
6. Adult ADHD significantly impacts on social, financial and personal aspects of life
7. Recent studies confirm significant underuse of colorectal cancer screening
8. VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
9. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
10. A Major Gift of Art and History: U-M Receives 45 Significant Medical Paintings From Pfizer
11. International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Indianapolis, IN (PRWEB) , ... April 25, 2017 ... ... Washington, D.C., CEOs, CFOs and HR decision-makers are preparing for how his administration ... Life Financial will provide insight into what changes are most likely to make ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in ... to dispensaries and head shops –can’t help but be heartened by the industry’s current ... cannabis odor aptly described as “skunk smell.” At last they can simply, safely ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ... offering. ... market was valued at US$ 7,167.6 Mn in 2015, and ... at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: